What Tempus AI Multiomics does
Tempus multiomics platform integrates genomic, transcriptomic, and proteomic data with AI to create comprehensive tumor profiles. Oncologists receive the most complete picture of each cancer for optimal treatment selection.
How Tempus AI Multiomics compares with its closest alternatives
1 of the 5 closest alternatives has a free plan; Tempus AI Multiomics does not. All 5 offer an API, as Tempus AI Multiomics does. Tempus AI Multiomics offers a web app. Of the alternatives, all 5 offer a web app. Tempus AI Multiomics was founded in 2024; the alternatives were founded between 2000 and 2021, 5 of them earlier. Tempus AI Multiomics is based in Chicago, United States; 2 of the 4 alternatives with a known headquarters are in the United States too, and the others in the United Kingdom and France.